Winn-Dixie Announces Community Donation Program to Benefit Ochsner Cancer Institute

Winn-Dixie announces the launch of a community donation program during the month of October to raise funds for the Ochsner Cancer Institute. All money raised will help the renowned institution in providing exceptional treatment and health care to individuals living with cancer and offer essential support and resources to families of cancer patients.

Now through Oct. 26, Winn-Dixie customers can round up their grocery total at checkout or make donations of their choice at the register in all Louisiana stores to support local patients at the Ochsner Cancer Institute. Ochsner’s cancer centers across the state have been dedicated to cancer research and new cancer treatment development for more than 70 years. The funds raised will directly benefit the Ochsner Cancer Institute with a goal of positively impacting the quality of life of patients by offering world-class care at one of the top cancer facilities in the Gulf South.

Joey Medina, Regional Vice President at Winn-Dixie, said, “Winn-Dixie has a 65-year history of serving our communities along the Gulf Coast – a region known for resilience in the face of adversity. We are honored to continue our support of the Ochsner Cancer Institute as they strive to offer quality service and insurmountable strength to people when they need it most. Winn-Dixie commends Ochsner for its devotion to patients and families, and we stand with the institution in its tremendous dedication to making our communities stronger.”

Winn-Dixie is committed to partnering with organizations like the Ochsner Cancer Institute, one of the largest comprehensive cancer centers in the Gulf South region. The health system provides the personalized care and state-of the-art treatment critically needed to build healthier communities. Ochsner Cancer Institute aims to provide the highest level of care in the region to patients by offering advanced technology and treatment options so that patients do not have to leave the state for high-quality cancer care. Ochsner’s integrative oncology program underscores an important focus of the institute’s multidisciplinary approach: the social, physical and emotional impacts of cancer treatment. At the Ochsner Cancer Institute, disease-specific teams collaborate to deliver outstanding outcomes and help patients and their families navigate this complex disease and its treatment.

Shon Cowan Baker, PhD, Vice President for Philanthropy at Ochsner Health, said, “The Ochsner Cancer Institute believes in offering high quality care close to home. Thanks to the ongoing support from Winn-Dixie and the communities we serve, Ochsner Cancer Institute is able to deliver the lifesaving care needed to build a healthier community – for today and generations to come.”

Winn-Dixie is honored to continue its longstanding partnership with Ochsner Health, an organization that shares the grocer’s dedication to caring for the community during challenging times. Since 2017, Winn-Dixie and its generous customers have donated more than $320,000 to Ochsner Health to support the wellbeing of patients and families along the Gulf Coast.

Additionally, Winn-Dixie and its parent company, Southeastern Grocers, together with the donations from generous customers, recently raised more than $112,000 to support hunger relief. This donation is in addition to the grocer’s charitable foundation’s contribution of $150,000 to Feeding America® network food banks for Hunger Action Month®, including $25,000 to Second Harvest Food Bank in New Orleans.

Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Tabrecta is the first FDA-approved therapy to treat non small cell lung cancer with specific mutations (those that lead to mesenchymal-epithelial transition or MET exon 14 skipping).
The Cor® TRICUSPID ECM® valve has been successfully implanted in the 11th patient enrolled in the expansion by Dr. Marc Gerdisch, Chief of Cardiothoracic Surgery at Franciscan Health Heart Center in Indianapolis, Indiana & principal investigator for the adult component of the study.
Thirona notes LungQ 3.0.0 builds on 10 years of clinical trials and 200+ publications to deliver advanced segmentation of pulmonary segments and subsegments.
The Zeta Surgical Cranial Navigation System is a mixed-reality navigation system for neurosurgery, providing surgeons with "GPS-like" guidance with millimetric accuracy in real-time. Zeta's computer vision engine ensures maintained accuracy by automatically registering multiple times a second, accounting for patient movement, and allowing for awake and non-immobilized use in both operative and extra-operative settings.
The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements.

By using this website you agree to accept Medical Device News Magazine Privacy Policy